GRHL2 and acute leukemia: Subsequently, to investigate whether the low expression of GRHL2 in patients with acute leukemia is related to the high methylation level of the promoter region, we treated acute leukemia cell lines KG-1 and BALL-1 with the demethylation drug arsenic trioxide and 5-azacitidine.